Top Stories
All Sections
Finance
About
8 results for "health AI"
Oura agreed to buy Counsel Health, an AI-native primary care company, for $625 million — one of the largest health AI acquisitions of 2026 — signaling a pivot from wearable data collector to continuous care platform.
A proof-of-concept study demonstrates that AI foundation models trained on wearable sensor data can predict migraines a full 24 hours before onset — the first multimodal wearable AI demonstration for migraine forecasting.
Pathos AI raised $237 million in Series E funding at a $3 billion valuation, using AI to match cancer patients to clinical trials and identify drug response patterns — one of the largest health AI raises of 2026.
Of 1,357 AI-powered medical tools approved by the FDA, only three were evaluated on patient outcomes. The rest cleared on technical benchmarks with no proven connection to whether patients fare better.
Twelve major U.S. health systems have joined Aidoc in a formal consortium to share AI governance frameworks and outcomes data—and publish a replicable playbook for hospitals still on the sidelines.
A new study finds patients consistently withhold symptoms from AI health chatbots, creating a diagnostic gap that undermines real-world accuracy even as AI outperforms doctors on benchmarks.
Patients share significantly less symptom detail with AI diagnostic chatbots than with human physicians, and that disclosure gap could undermine clinical accuracy regardless of how well the underlying models perform.
Only 42% of Americans are open to AI being used in their healthcare — down from 52% in 2024 — even as hospital systems accelerate AI deployment across clinical, diagnostic, and documentation workflows.